4.7 Article

Flavonoid Glycosides from Fenugreek Seeds Regulate Glycolipid Metabolism by Improving Mitochondria! Function in 3T3-L1 Adipocytes in Vitro

Journal

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
Volume 66, Issue 12, Pages 3169-3178

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.jafc.8b00179

Keywords

fenugreek seeds; flavonoid glycosides; isoorientin; insulin resistance; 3T3-L1 adipocytes; mitochondrial function

Funding

  1. National Science Foundation of China [31470426]
  2. Qinghai Provincial Science Foundation [2015-SF-121]
  3. Personalized Medicines-Molecular Signature-based Drug Discovery and Development
  4. Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12040320]
  5. Shandong Provincial Science Foundation [ZR2017MH024]
  6. Shuangbai Project of Yantai
  7. Youth Innovation Promotion Association, CAS

Ask authors/readers for more resources

Fenugreek is a well known annual herb widely used in both medicine and food. Four flavonoid glycosides have been separated from fenugreek seeds in our previous study. In this study, the effects of the four flavonoid glycosides on regulating glycolipid metabolism and improving mitochondrial function were investigated. Isoorientin showed a very significant activity among these flavonoid glycosides. First, isoorientin decreased the accumulation of lipid droplets in 3T3-L1 preadipocytes by reducing the expression of adipokines including PPARy, C/EBP alpha, and FAS. Second, isoorientin restored insulin-stimulated glucose uptake in dexamethasone-induced insulin-resistant 3T3-L1 adipocytes by reactivating Akt and AMPK. Finally, isoorientin improved mitochondrial dysfunction induced by dexamethasone in 3T3-L1 adipocytes. Isoorientin also reversed dexamethasone-induced decrease in mitochondrial membrane potential (MMP) and intracellular ATP production, reduced accumulation of intracellular reactive oxygen species (ROS), and protected mitochondrial DNA (mtDNA) from oxidative damage. At the same time, mitochondrial biogenesis is promoted. Therefore, isoorientin may be an attractive candidate as a glucose-lowering and insulin-resistance-improving agent for the treatment of diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available